Moderna ties up with Immatics to boost cancer vaccine development https://ift.tt/67AwGfC

The deal is the latest in Moderna's push to expand beyond COVID as demand for the shots falls dramatically, and develop a vaccine for cancer, a dream that scientists have chased for decades with little success. Moderna is already developing a cancer vaccine with Merck, which was shown to cut the risk of recurrence or death by 44 per cent in patients with deadly skin cancer melanoma, in a mid-stage trial. It also has vaccines under development for flu and respiratory syncytial virus (RSV), among others.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/jnc3xoy